Total neoadjuvant chemoradiation combined with neoadjuvant PD-1 blockade for patients with pMMR, high-risk, and locally advanced middle to low rectal cancer.

Authors

null

Aiwen WU

Peking University Cancer Hospital and Institute, Beijing Cancer Hospital, Beijing, China

Aiwen WU , Yingjie Li , Dengbo Ji , Li Zhang , Xiaoyan Zhang , Yong Cai , Yangzi Zhang , Yunfeng Yao , Lin Wang , Jiahua Leng , Tiancheng Zhan , Ying-Shi Sun , Zhongwu Li , Xiaoli Cui , Haitao Luo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer - Neo-Adjuvant/Adjuvant

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3611)

DOI

10.1200/JCO.2022.40.16_suppl.3611

Abstract #

3611

Poster Bd #

405

Abstract Disclosures